Buy a research peptide for a lab and three documents can end up in the file: a specification sheet, a certificate of analysis and a safety data sheet. They are easy to confuse, and none of them can stand in for another. The short version of COA vs SDS: a certificate reports what one lot measured, a safety data sheet explains a product’s hazards and how to handle it safely, and the specification is the yardstick the certificate is measured against.
This article centres on the safety data sheet, the only one of the three that Canada’s workplace hazard rules require for hazardous products: what it must contain under WHMIS 2015, who owes it to whom, and how it differs from the other two.
The short answer
- Three documents answer three questions. A specification sheet says what a product should be; a certificate of analysis (COA) reports what one lot measured against it; a safety data sheet (SDS) describes the product’s hazards and safe handling.
- In Canada, the SDS is a regulated WHMIS document. Section 13 of the Hazardous Products Act bars a supplier from selling a hazardous product intended for workplace use unless it has a compliant SDS and provides it to the purchaser.
- Every WHMIS SDS has 16 sections in a fixed order. Schedule 1 of the Hazardous Products Regulations runs from Identification to Other information; headings 12 to 15 must appear, but their content may be omitted.
- An SDS describes a product; a COA describes a lot. One SDS serves every lot under a product identifier; accredited test reports must state that the results relate only to the items tested (ISO/IEC 17025:2017).
- “No data available” means unknown, not harmless. The regulations require an SDS to declare missing information, and a purity figure carries no hazard information at all.
- File by lot, but keep the SDS within reach. Specifications and COAs belong with the lot record; SDSs must be readily available to the workers who may be exposed.
Safety data sheet (SDS)
SDS · WHMIS safety data sheet · the hazard document for a hazardous product
- What it is
- A summary of a product’s hazards and how to handle, store, clean up and dispose of it
- Canadian rules
- Hazardous Products Act and Regulations (SOR/2015-17)
- Who provides it
- The supplier that sells or imports a hazardous product, at the time of sale
- Format
- 16 numbered headings in a fixed order (Schedule 1)
- Languages
- English and French (section 6.2)
- Updates
- Within 90 days of significant new data; no three-year renewal for suppliers
- Employer side
- Provincial or territorial health and safety law, or the Canada Labour Code in federal workplaces
- What it is not
- A specification, a test report or evidence about any particular lot
What an SDS can support
- Knowing the product’s classified hazards
- Choosing controls, PPE, spill and disposal steps
- Confirming the identity or purity of your lot
- Showing that an unstudied product is harmless
An SDS is only as complete as the hazard data behind it, and gaps must be declared.
COA vs SDS vs spec sheet: three documents, three questions
Ask two things of each document: which question it answers, and whether it describes the product in general or one particular lot.
| Document | Question it answers | Scope | Who issues it | What shapes it | What it cannot tell you |
|---|---|---|---|---|---|
| Specification sheet | What should this product be? | The product, all lots | Manufacturer or supplier | Supplier practice; ICH Q6A defines the term for drugs | Whether any lot met it |
| Certificate of analysis | What did this lot measure? | One lot | Quality unit or testing laboratory | ICH Q7 for drugs; ISO/IEC 17025 for accredited reports | Hazards, or anything about other lots |
| Safety data sheet | What are the hazards, and how is it handled safely? | The product, by product identifier | The supplier that sells or imports it | Hazardous Products Act and Regulations | The identity or purity of your lot |
Two of the three describe a product; only one describes a lot. An SDS does not go out of date because the lot number changed, and a certificate does not transfer to a new vial because the product name matches.
Want to see how a certificate reads in practice? Our COA guide walks through every line.
Read the COA guideThe safety data sheet: hazard communication under WHMIS 2015
The Canadian Centre for Occupational Health and Safety (CCOHS) describes safety data sheets as “summary documents that provide information about the hazards of a product”, with more detail than the label. The rules sit in the federal Hazardous Products Act and the Hazardous Products Regulations, which took effect on February 11, 2015, replaced the Controlled Products Regulations and aligned WHMIS with the Globally Harmonized System (GHS). Amendments in force since December 15, 2022 track the GHS’s seventh revised edition and parts of the eighth; Health Canada says they “provided a 3-year transition period that ended on December 14, 2025”.
The obligation follows a classification, not a type of product. Under the Act, a hazardous product is anything “classified in accordance with the regulations” in a hazard class, and section 13 bars a supplier — a person who, “in the course of business, sells or imports a hazardous product” — from selling one for workplace use without a compliant SDS, provided to the purchaser. Whether a given research compound meets any hazard-class criteria is a classification question for its supplier; this article makes no claim either way about any peptide.
What the 16 sections contain
Section 4 of the regulations requires every Schedule 1 heading, numbered and in order. Where a required item is unavailable or does not apply, “an indication to that effect must be clearly stated”, and the product and supplier identifiers “must be identical to those provided on the label”, so section 1 is where you confirm you have the right sheet.
| Section | What it must contain (abridged from Schedule 1) |
|---|---|
| 1. Identification | Product identifier, recommended use and restrictions, supplier, emergency number |
| 2. Hazard identification | Classification, label elements, other known hazards |
| 3. Composition/Information on ingredients | Chemical name, synonyms and CAS number; for mixtures, health-hazard ingredients and their concentrations |
| 4. First-aid measures | Measures needed, main symptoms and effects, any need for immediate medical attention |
| 5. Fire-fighting measures | Extinguishing media, specific hazards, protection for firefighters |
| 6. Accidental release measures | Personal precautions and protective equipment; containment and clean-up methods |
| 7. Handling and storage | Safe handling; safe storage conditions, including incompatibilities |
| 8. Exposure controls/Personal protection | Exposure limits and their source, engineering controls, PPE |
| 9. Physical and chemical properties | Eighteen properties, including physical state and particle characteristics |
| 10. Stability and reactivity | Stability, reactivity, conditions to avoid (“including static discharge, shock or vibration”), incompatible materials |
| 11. Toxicological information | Routes of exposure, symptoms, acute and chronic effects, measures of toxicity |
| 12 to 15. Ecological, disposal, transport, regulatory | Headings required; content may be omitted in Canada |
| 16. Other information | Date of the latest revision |
For a dry research powder, sections 2 and 6 to 11 carry most of the practical information, and section 16 dates the sheet. The bench side — weighing, static, spills, labels and waste — is in our companion guide to handling peptide powders safely under WHMIS.
Supplier duties and employer duties
Supplier duties are federal. The SDS “must be provided by the suppliers of the hazardous products at the time of sale”, CCOHS notes, in English and French — one bilingual sheet or two unilingual parts (section 6.2) — and a website address alone does not meet the duty. Suppliers no longer have to renew an SDS every three years. Instead, section 5.12 gives them 90 days from the date significant new data become available — data that change the classification or the ways to protect against the hazard — to bring the SDS up to date, and buyers in that window must be given a document setting out the required changes and that date. Section 5.11 spares a supplier from re-sending an SDS to a buyer who already holds a current one for the same product identifier: the sheet belongs to the product, not the lot.
Employer duties sit in provincial and territorial health and safety law, or the Canada Labour Code and Part X of the Canada Occupational Health and Safety Regulations in federal workplaces. Hazardous products must arrive with an up-to-date SDS, kept “readily available to the workers who are exposed”; Ontario’s guide reads that as close to the workers and accessible during every shift, on paper or electronically. CCOHS notes that employers in federally regulated workplaces, British Columbia, Saskatchewan, Newfoundland and Labrador, the Northwest Territories, Nova Scotia, Nunavut and Yukon must still actively seek an updated SDS every three years. Laboratory exemptions are narrow. A “laboratory sample” is material in a container of less than 10 kg intended solely to be tested in a laboratory, not material the laboratory uses to test other things or for teaching, and its reduced label and SDS rules apply only in limited cases, such as a sample of unknown composition handed over for testing without a sale (section 5). As Ontario’s guide notes, WHMIS 2015 also eliminated the old exemptions for products from a laboratory supply house.
The specification sheet: what the product should be
ICH Q6A, a drug guideline, defines a specification as “a list of tests, references to analytical procedures, and appropriate acceptance criteria”, and conformance as meeting those criteria when tested by the listed procedures; ICH Q7 opens its own definition with the same words. Quoting pharmaceutical frameworks makes no claim about which rules apply to a laboratory reagent. Q6A’s universal tests are description, identification, assay and impurities. For a synthetic peptide those might become an appearance statement, a mass spectrometry identity test, an HPLC purity criterion and a content figure, and Q6A says its approach may apply to “synthetic peptides of low molecular weight” but is not sufficient for larger peptides and polypeptides.
Commercially, the document may be called a specification sheet, a product data sheet or a technical data sheet. We found no Canadian rule that fixes its contents, so read the content, not the title, and separate acceptance criteria, which each lot is tested against, from “typical” values, which commit to nothing about your lot. Recommended storage conditions on a product sheet concern stability, a different question from the safe storage covered in section 7 of an SDS. What a specification cannot do is report anything: Q6A calls specifications “one part of a total control strategy”. A specification sets the pass mark without showing that any lot sat the test.
The certificate of analysis: what one lot measured
A certificate of analysis is the measurement set against the specification, and the only one of the three documents tied to a single lot. ICH Q7, the GMP guide for active pharmaceutical ingredients, says certificates “should be issued for each batch” on request, giving the batch number, the date of release and each test with “the acceptance limits, and the numerical results obtained”, dated and signed by authorized quality-unit personnel; a new certificate issued by or for an agent or broker should name the laboratory that did the analysis, refer to the original manufacturer and attach a copy of the original batch certificate. ISO/IEC 17025:2017 requires accredited reports to state that the results relate only to the items tested — they “cannot be extended to other items”, as European Accreditation puts it. That makes the SDS vs COA difference plain: a certificate is evidence about a tested sample with no hazard information, and an SDS is hazard information with no evidence about any sample. Our guide on how to read a certificate of analysis covers the rest line by line.
What none of the three can prove
Some things sit outside all three, however accurate they are.
- Suitability beyond the bench. None of the three is evidence that a material is safe or suitable for human or animal use.
- The absence of a hazard. Classification works from available data, and missing data must be declared rather than filled in. A barely studied compound can carry a sheet full of “no data available”, or no classification at all, and neither is reassuring.
- What happened after dispatch. A certificate describes the sample on the day it was tested; transit and storage are outside every document in the set.
- Their own accuracy. Documents can be out of date, mismatched or wrong. Check that the identifiers on the SDS and the label match, that the revision date is current, and that the certificate’s lot number matches the vial.
How to file the three documents in a lab
Different scopes mean different places, linked by the lot number.
- Specification and certificate go with the lot, beside the supplier’s lot number and your own receiving number. Our guide to lot numbers shows how to match documents to a lot number.
- The SDS goes where workers can reach it on every shift. Note the section 16 revision date, and file superseded sheets with the date they were replaced.
- The inventory ties them together. CCOHS recommends that laboratories keep an up-to-date chemical inventory and review each SDS. Link both records from the inventory entry, and check all three documents at receipt rather than after an incident.
What’s established and what isn’t
Established, and citable
- A supplier may not sell a hazardous product for workplace use without a compliant SDS (Hazardous Products Act, section 13).
- WHMIS SDSs use 16 numbered headings in a fixed order; content under 12 to 15 is optional (Regulations, section 4 and Schedule 1).
- Missing information must be declared (section 4).
- SDSs and labels must be in English and French (section 6.2).
- Significant new data starts a 90-day SDS window and a 180-day label window (section 5.12).
- Employers in federal workplaces and seven provinces and territories must still seek an updated SDS every three years (CCOHS).
- A specification lists tests, analytical procedures and acceptance criteria (ICH Q6A; ICH Q7).
- Accredited test reports are limited to the items tested (ISO/IEC 17025:2017).
Open, or outside what the documents can show
- Whether a particular research peptide meets any WHMIS hazard-class criteria: a classification for its supplier, on which this article takes no position.
- Hazards nobody has measured; an SDS can only report data that exist.
- Which framework, if any, governs a reagent’s specification or certificate; ICH guidance is written for drugs.
- Whether a certificate is genuine, beyond what matching lot numbers show.
- What happened to a container in transit.
Asking a Canadian supplier for documents
A specific request gets better answers than “send me your paperwork”. Four questions cover most of it.
- Is the product classified as a hazardous product under the Hazardous Products Regulations? If so, the current SDS should be bilingual and dated in section 16; if not, ask what the classification was based on.
- Which specification is the certificate measured against, and which version?
- Does the certificate carry the lot number on my vial? If not, it describes other material.
- Has anything changed since my last order? A revised SDS, a new specification version and a new lot can all arrive with a repeat purchase.
If your institution wants documentation on file before a product enters its chemical inventory, ask your environmental health and safety office what it needs before ordering. Pure Peptides Canada is itself a supplier, so apply the same questions to us. Start with the Lab Testing page; to ask for an SDS, a specification or any other product document, use our contact page.
See a certificate of analysis for yourself
Janoshik test reports for the research peptides below are listed on our Lab Testing page. Read one with this guide in hand: check what was tested and by whom, and whether its batch number matches your vial.
Research use only. Pure Peptides Canada products are laboratory reagents for in-vitro research, not for human or veterinary use. This article explains workplace hazard documents and quality documents for education; it is not medical, dietary or dosing guidance, and it is not legal or regulatory advice.
Frequently asked questions
What is the difference between a COA and an SDS?
A certificate of analysis reports what one lot measured, such as identity and purity, against the limits in its specification. A safety data sheet describes a product’s hazards and safe handling, and in Canada it is the WHMIS document required for hazardous products. A COA belongs to one lot; an SDS covers the product.
What is a specification sheet for a research peptide?
It states what the product is supposed to be: the tests it is checked by, the methods used and the acceptance criteria each lot must meet. For a synthetic peptide that might mean an appearance statement, an identity test, a purity criterion and a content figure. It describes the target, not the measured values for any lot.
Is a safety data sheet required in Canada?
For hazardous products, yes. Under the Hazardous Products Act, a supplier may not sell a hazardous product intended for use in a Canadian workplace without a compliant safety data sheet, which it must provide to the purchaser. Whether a product is a hazardous product depends on its classification under the Hazardous Products Regulations.
How many sections does an SDS have under WHMIS?
Sixteen, in a fixed order set by Schedule 1 of the Hazardous Products Regulations, from Identification to Other information, which gives the date of the latest revision. The headings for sections 12 to 15 must appear, but their content may be omitted in Canada. The sheet must be in English and French.
Does a COA prove a product is safe?
No. A certificate of analysis reports measurements such as identity and purity for one lot and carries no hazard information. A highly pure compound can still be hazardous to handle, and no certificate is evidence that a material is suitable for human or animal use.
Which documents should a lab keep for each peptide lot?
Keep the certificate of analysis whose lot number matches the vial, the specification version it was measured against, and a receiving record with the supplier’s lot number and your own. Keep the current safety data sheet, where one applies, where workers can reach it on every shift, and note its revision date.
Keep the right paperwork with every lot
Questions about a product’s documentation? Ask us, and see the certificates on our Lab Testing page.
References
- Canadian Centre for Occupational Health and Safety. WHMIS – Safety Data Sheet (SDS). OSH Answers fact sheet, last revised 2026-05-28. CCOHS
- Canadian Centre for Occupational Health and Safety. WHMIS – General. OSH Answers fact sheet, last revised 2026-05-28. CCOHS
- Canadian Centre for Occupational Health and Safety. WHMIS – Laboratories. OSH Answers fact sheet, last revised 2026-05-28. CCOHS
- Government of Canada. Hazardous Products Act (R.S.C., 1985, c. H-3), sections 2 and 13. Justice Laws Website
- Government of Canada. Hazardous Products Regulations (SOR/2015-17), sections 4, 4.2, 5, 5.11, 5.12 and 6.2, and Schedule 1. Justice Laws Website
- Health Canada. Amended Hazardous Products Regulations. Government of Canada
- Health Canada. Frequently Asked Questions – Hazardous Products Regulations. Government of Canada
- Government of Canada. Canada Occupational Health and Safety Regulations (SOR/86-304), Part X, Division III. Justice Laws Website
- Government of Ontario. Workplace Hazardous Materials Information System: A guide to the legislation – WHMIS and the employer. Updated 2026-03-31. Ontario.ca
- Government of Ontario. Workplace Hazardous Materials Information System: A guide to the legislation – Special applications of WHMIS. Updated 2026-03-31. Ontario.ca
- International Council for Harmonisation. ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. CPMP/ICH/367/96, sections 1.2, 1.3 and 3.2.1. European Medicines Agency
- International Council for Harmonisation. ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. CPMP/ICH/4106/00, sections 11.40–11.44 and Glossary. European Medicines Agency
- European co-operation for Accreditation. Question on reporting, ISO/IEC 17025:2017 clause 7.8.2.1 l). European Accreditation
For laboratory research use only. Not for human or veterinary use. This article summarizes published regulatory and standards material for educational purposes and is not medical, legal or regulatory advice.

BPC-15715-amino-acid research peptideView product
TB-500Thymosin beta-4 research peptideView product
GHK-CuCopper tripeptideView product
EpithalonLyophilized tetrapeptideView product